TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii):
INTERNATIONAL BIOTECHNOLOGY TRUST PLC
2. Reason for the notification (please place an X inside the appropriate bracket/s):
An acquisition or disposal of voting rights: (X)
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ()
An event changing the breakdown of voting rights: ()
Other (please specify): ()
3. Full name of person(s) subject to the notification obligation (iii):
AXA S.A, 25 Avenue Matignon, 75008 Paris and its group of companies
4. Full name of shareholder(s) (if different from 3.) (iv):
N/A
5. Date of the transaction (and date on which the threshold is crossed or reached if different) (v):
11 August 2009
6. Date on which issuer notified:
18 August 2009
7. Threshold(s) that is/are crossed or reached:
5%
8. Notified details:
A: Voting rights attached to shares
Class/type of shares if possible using the ISIN CODE |
Situation previous to the Triggering transaction (vi) |
|
|
Number of shares |
Number of voting Rights (viii) |
Ordinary Shares GB0004559349 |
3,319,041 |
3,319,041 |
Resulting situation after the triggering transaction (vii)
Class/type of shares if possible using the ISIN CODE |
Number of shares |
Number of voting rights (ix) |
% of voting rights |
||
|
|
Direct (x) |
Indirect (xi) |
Direct |
Indirect |
Ordinary Shares GB0004559349 |
3,219,041 |
3,219,041 |
0 |
4.97% |
0 |
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction (xii)
Type of financial instrument |
Expiration Date (xiii) |
Exercise/Conversion Period/ Date (xiv) |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
% of voting rights |
N/A |
N/A |
N/A |
N/A |
N/A |
C: Financial Instruments with similar economic effect to Qualify Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument |
Exercise price |
Exercise/Conversion Period |
Number of voting rights instrument refers to |
% of voting rights |
|
|
|
|
|
Nominal |
Delta |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total (A+B+C)
Number of voting rights |
% of voting rights |
3,219,041 |
4.97% |
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xv):
Name of the Company/Fund |
Number of Shares |
% of issued share capital |
AXA IM UK |
3,203,329 |
4.94 |
Sun Life International (IOM) Ltd |
15,712 |
0.03 |
-------------------- |
-------------- |
------------- |
Total |
3,219,041 |
4.97 |
Proxy Voting:
10. Name of the proxy holder:
N/A
11. Number of voting rights proxy holder will cease to hold:
N/A
12. Date on which proxy holder will cease to hold voting rights:
N/A
13. Additional information:
N/A
14. Contact name:
RACHAEL NELSON, FOR AND ON BEHALF OF BNP PARIBAS SECRETARIAL SERVICES LIMITED
15. Contact telephone number:
020 7410 3132
Date: 18 AUGUST 2009